Premium Serums & Vaccines Pvt. Ltd. (India)

Premium Serums & Vaccines Pvt. Ltd. (PSVPL), commonly known as Premium Serums, is an Indian biopharmaceutical company based in Narayangaon, Maharashtra. It was founded in 2009 by Dr. Shyam Dhawan, Dr. Girish Kolwankar and Dr. Milind Khadilkar with the specific objective of manufacturing a wide range of life-saving equine immunoglobulin products that were in short supply not only in India but also in many parts of the world, leading to avoidable loss of lives. The company describes itself as one of India's leading equine immunoglobulin manufacturing companies and as a technology-driven, professionally run enterprise. Premium Serums develops and manufactures equine therapeutic immunoglobulins — enzyme-refined antibody preparations produced in horses — across several therapeutic categories. Its portfolio includes snake venom antiserums, scorpion venom antiserums, rabies antiserum, tetanus antitoxin and diphtheria antitoxin. Products are supplied both as liquid formulations and as lyophilized (freeze-dried) combipacks with sterile water for injection. The company has developed region-specific snake antivenoms for different geographical areas as recommended by the World Health Organization, including products tailored to India, Pan Africa and North Africa. A landmark achievement is the WHO, Geneva approval of its manufacturing facility for the production of PANAF-Premium™ (Snake Venom Antiserum Pan Africa). This product is recommended by the WHO for the treatment of snakebite envenoming by 24 of the most medically important species in sub-Saharan Africa, based on a positive risk-benefit assessment. The company has also developed region-specific antivenom for Sri Lanka. Premium Serums positions itself around affordability and access: it states that it serves the most marginalized and least empowered communities by providing cost-effective, good-quality, region-specific product options, and that its affordable products are reaching newer destinations for better healthcare globally. Its products are widely distributed in India and regularly exported to many countries, giving the company a wide global footprint. In addition to finished formulations, Premium Serums exports bulk products to other manufacturers and provides technology to produce finished formulations at their facilities. The company remains a private limited entity and is not listed on a stock exchange. It continues to operate from its Narayangaon base, combining need-based product development with modern technology and a mission summarized as "Premium products to save precious lives."

Premium Serums and Vaccines Private Limited (PSVPL) was founded in 2009 by Dr. Shyam Dhawan, Dr. Girish Kolwankar and Dr. Milind Khadilkar. The founders established the company with a specific objective: to manufacture a wide range of life-saving equine immunoglobulin products that were in short supply not only in India but also in many parts of the world, where shortages led to unfortunate incidences of loss of lives. From its base in Narayangaon, Maharashtra, the company set out to produce these biological products at affordable prices, aiming to save thousands of lives every year. Over more than a decade of research and development, Premium Serums built a portfolio of equine therapeutic immunoglobulins spanning antivenoms, antiserums and antitoxins. The company developed region-specific snake antivenom products for various geographical areas as recommended by the World Health Organization. A notable early success was the development of a region-specific antivenom for Sri Lanka, which the company cites as an example of its approach to need-based product development. A major milestone was the approval of the company's manufacturing facility by the World Health Organization, Geneva, for the manufacture of PANAF-Premium™ (Snake Venom Antiserum Pan Africa). This product is recommended by the WHO for the treatment of snakebite envenoming by 24 of the most medically important species in sub-Saharan Africa, based on a positive risk-benefit assessment. The approval positioned Premium Serums as a supplier of WHO-recommended antivenom for African markets, complementing its North Africa-focused NORAF-Premium® and ANTISCORP-Premium™ products. Alongside its antivenom range, the company developed antitoxins such as Premi-TAT® tetanus antitoxin and diphtheria antitoxin, and antiviral products such as Premi-RIG® rabies antiserum. Products are offered in liquid and lyophilized (freeze-dried) forms, often as combipacks with sterile water for injection. Premium Serums states that its products are widely distributed in India and regularly exported to many countries, giving it a wide global footprint. Beyond finished formulations, the company exports bulk products to manufacturers and provides technology to manufacture finished formulations at their facilities. It describes itself as a technology-driven company run by professionals, with a vision to be a leading manufacturer of good quality, safe and effective life-saving equine immunoglobulin products at affordable prices, and a mission of "Premium products to save precious lives." The company remains a private limited entity headquartered in Narayangaon, India.

• 2009

  Premium Serums and Vaccines Private Limited founded by Dr. Shyam Dhawan, Dr. Girish Kolwankar and Dr. Milind Khadilkar.

• Development of a region-specific antivenom for Sri Lanka, cited by the company as an example of need-based product development.

• Manufacturing facility approved by the World Health Organization, Geneva, for manufacture of PANAF-Premium™ (Snake Venom Antiserum Pan Africa).

• PANAF-Premium™ recommended by WHO for treatment of snakebite envenoming by 24 of the most medically important species in sub-Saharan Africa.

Affordable, region-specific, WHO-aligned equine immunoglobulin and antivenom products for underserved communities in India and globally.

• Combipack of Snake Venom Antiserum I.P. with Sterile Water for Injection

  Lyophilized, polyvalent, enzyme-refined equine immunoglobulins.

• Snake Venom Antiserum I.P.

  Polyvalent enzyme-refined equine immunoglobulins (liquid).

• PANAF-Premium™

  Combipack of Snake Venom Antiserum (Pan Africa) with sterilized water for injection B.P.; lyophilized, enzyme-refined equine immunoglobulins.

• NORAF-Premium®

  Combipack of Snake Venom Antiserum (North Africa) with sterilized water for injection B.P.; lyophilized, enzyme-refined equine immunoglobulins.

• ANTISCORP-Premium™

  Combipack of Scorpion Venom Antiserum North Africa with sterilized water for injection B.P.

• PREMISCORP-Premium™

  Combipack of Scorpion Venom Antiserum I.P. with sterile water for injection; lyophilized, monovalent enzyme-refined equine immunoglobulins.

• Premi-TAT® 1500 IU

  Tetanus Antitoxin B.P., enzyme-refined equine immunoglobulins (liquid).

• Premi-TAT® (FD) 1500 IU

  Tetanus Antitoxin B.P. with sterilized water for injection; lyophilized, enzyme-refined equine immunoglobulins.

• Diphtheria Antitoxin I.P.

  Enzyme-refined equine immunoglobulins (liquid), 10000 IU per vial.

• Diphtheria Antitoxin I.P. (FD)

  With sterile water for injection; lyophilized enzyme-refined equine immunoglobulins, 10000 IU.

• Premi-RIG® Rabies Antiserum

  1000 IU per vial, enzyme-refined equine immunoglobulins (liquid).

• Premi-RIG® (FD) Rabies Antiserum

  Lyophilized with sterilized water for injection B.P.; lyophilized, enzyme-refined equine immunoglobulins.

1. 1Premium Serums and Vaccines Pvt Ltd — Homepagepremiumserums.com
2. 2Premium Serums and Vaccines Pvt Ltd — About Uspremiumserums.com
3. 3Premium Serums and Vaccines Pvt Ltd — Productspremiumserums.com
4. 4Wikidata — Premium Serums & Vaccines Pvt. Ltd. (India)wikidata.org